Cinco Días lists Prof. Laura M. Lechuga among pioneers in the fight against cancer

Prof. Laura M. Lechuga, leader of the ICN2 Nanobiosensors and Bioanalytical Applications Group, was featured in a recent article in Spanish business and finance newspaper Cinco Días with the title “The faces behind the anti-cancer armoury of the future”.

Photo from Cinco Días (l-r: Laura Lechuga, Ángel Raya, Adriana Terrádez)

Timely detection is key to combating cancer and other diseases. The technology developed by the Nanobiosensors and Bioanalytical Applications Group, led by Prof. Laura M. Lechuga, has enormous potential for application in this area. It is also suitable for use in developing countries, where sophisticated laboratory equipment and facilities are not available.

Recently her work has been highlighted in an article in Cinco Días with the title “The faces behind the anti-cancer armoury of the future”, alongside that of Ángel Raya, of the Centre of Regenerative Medicine in Barcelona, and Adriana Terrádez, co-founder of BioSequence.

The full article can be consulted here (in Spanish).